Pharmaids Pharma

{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.63",
    "chg": 0.43,
    "chgp": "1.1%",
    "dir": 1,
    "prev_price": "39.20",
    "mcapval": "141.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE117D01018",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "1.12 k",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3827266",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_mojoScore_3827266.png",
        "date": "2026-02-08 10:10:17",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 08 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.40.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs405-3816458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3816458.png",
        "date": "2026-02-02 11:23:53",
        "description": "Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.40.5, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance. This fresh low reflects the challenges the company faces within the Pharmaceuticals & Biotechnology sector, as it continues to underperform relative to broader market indices."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3814866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3814866.png",
        "date": "2026-02-01 15:43:15",
        "description": "Pharmaids Pharmaceuticals Ltd has declined to a fresh 52-week low of Rs.40.6, marking a significant downturn amid broader market volatility and sector underperformance. The stock has now recorded a three-day consecutive fall, accumulating an 8.17% loss over this period, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low Amidst Weak Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-amidst-weak-financial-metrics-3811561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/PharmaidsPharma_priceRelatedfactors_3811561.png",
        "date": "2026-01-30 13:06:40",
        "description": "Pharmaids Pharmaceuticals Ltd has reached a new 52-week low, closing near Rs 41.1, marking a significant decline in its stock price amid ongoing financial pressures and subdued performance metrics."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.41.17",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs4117-3809074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/PharmaidsPharma_priceRelatedfactors_3809074.png",
        "date": "2026-01-29 09:58:56",
        "description": "Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.41.17 today, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3807399",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/PharmaidsPharma_mojoScore_3807399.png",
        "date": "2026-01-28 10:10:20",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Why is Pharmaids Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-pharmaids-pharmaceuticals-ltd-fallingrising-3802717",
        "imagepath": "",
        "date": "2026-01-24 00:52:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Volatility</strong></p>\n<p>The stock has been under pressure for the past two days, losing 7.37% in that period. Despite touching an intraday high of ₹46.99, the shares ultimately fell to their intraday low of ₹42.13, which is just 0.31% above the 52-week low. The wide trading range of ₹4.86 and an intraday volatility of 5.45% indicate heightened uncertainty among investors. Notably, the weighted average price suggests that more volume was traded near the lower end of the price range, signalling selling pressure.</p>\n<p>Pharmaids Pharmaceuticals is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical weakness often discourages short-term and medium-term investors, contributing to further..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3781608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/PharmaidsPharma_mojoScore_3781608.png",
        "date": "2026-01-05 10:11:38",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 05 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3769248",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PharmaidsPharma_mojoScore_3769248.png",
        "date": "2025-12-25 12:57:37",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 97,
    "sid": "799751",
    "stock_news_url": "https://www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "09-Feb-2026",
      "details": "Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Re-Lodgement Of Requests For Transfer Of Physical Shares",
      "datetime": "16-Jan-2026",
      "details": "Report on shares re-lodged for transfer cum Demat of Physical shares.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(12 Feb 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-02-08 10:10:17

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 08 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.40.5

2026-02-02 11:23:53

Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.40.5, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance. This fresh low reflects the challenges the company faces within the Pharmaceuticals & Biotechnology sector, as it continues to underperform relative to broader market indices.

Read full news article

Pharmaids Pharmaceuticals Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-02-01 15:43:15

Pharmaids Pharmaceuticals Ltd has declined to a fresh 52-week low of Rs.40.6, marking a significant downturn amid broader market volatility and sector underperformance. The stock has now recorded a three-day consecutive fall, accumulating an 8.17% loss over this period, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low Amidst Weak Financial Metrics

2026-01-30 13:06:40

Pharmaids Pharmaceuticals Ltd has reached a new 52-week low, closing near Rs 41.1, marking a significant decline in its stock price amid ongoing financial pressures and subdued performance metrics.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.41.17

2026-01-29 09:58:56

Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.41.17 today, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-01-28 10:10:20

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Why is Pharmaids Pharmaceuticals Ltd falling/rising?

2026-01-24 00:52:21

Recent Price Movements and Volatility

The stock has been under pressure for the past two days, losing 7.37% in that period. Despite touching an intraday high of ₹46.99, the shares ultimately fell to their intraday low of ₹42.13, which is just 0.31% above the 52-week low. The wide trading range of ₹4.86 and an intraday volatility of 5.45% indicate heightened uncertainty among investors. Notably, the weighted average price suggests that more volume was traded near the lower end of the price range, signalling selling pressure.

Pharmaids Pharmaceuticals is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical weakness often discourages short-term and medium-term investors, contributing to further...

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-01-05 10:11:38

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 05 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2025-12-25 12:57:37

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News